André Verheem

1PUBLICATIONS
16CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 22, 2026
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-dependent, DR4-transactivation-mediated apoptosis.

Pageof 1

Frequent Collaborators

1 joint publications

Jamila Laoukili

1 joint publications

Ilse Jongerius

1 joint publications

Bart E C G de Goeij

1 joint publications

Madelon Paauwe